chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Pruritus, Rash
Clinical narrative: Rash; Pimples on face and neck area; Itching; This is a spontaneous report received from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration on left arm on 18Mar2021(at the age of 71-years-old), as a single dose for COVID-19 immunisation. No known medical history. The patient was allergic to amoxicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included multivitamin (MANUFACTURER UNKNOWN) for unknown indication, Alendronate (FOSAMAX) for unknown indication, fish oil (MANUFACTURER UNKNOWN) for unknown indication, vitamin D (MANUFACTURER UNKNOWN) for unknown indication, eye vitamin (MANUFACTURER UNKNOWN) for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient was not tested positive for COVID-19. On 18Mar2021 at 17:00, the patient experienced rash, pimples on face and neck area and itching. The patient did not received treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rash, pimples and itching was not resolved. No follow up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Chills; Tiredness; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 21Mar2021 (at the age of 57 years) at 14:00, as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis and COVID-19. The patient was allergic to strawberries. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced chills and tiredness on 22Mar2021. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills and tiredness was resolving at the time of this report.   No follow-up attempts needed. No further information expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 28- years-old) at 16:15 as a single dose for COVID-19 immunisation. Medical history was not reported. There were no known allergies to medications, food, or other products. The patient did not receive any medication within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. The patient had not been tested for COVID-19, since the vaccination. On 21Mar2021, the patient experienced dizziness at 16:30. It was unknown if the patient received any treatment for the event. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event dizziness was not recovered at the time of report.  Information about batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: Missed menstrual period for the same month I received my 2nd dose.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old female non-pregnant patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL9261) via unspecified route of administration in the left arm on 05Feb2021 at 09:15 (at the age of 22 years old) as a single dose for Covid-19 immunisation. The patients medical history included chronic migraine. Concomitant medication included Norethindrone Acetate (MANUFACTURER UNKNOWN) and Ethinyl Estradiol (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL0140) via unspecified route of administration in the left arm on 15Jan2021 at 09:15 (at the age of 22 years old) as a single dose for Covid-19 immunisation and previously took aloe Vera and experienced an Allergies. Prior to vaccination, Patient had no symptoms associated with COVID-19. The patient had not tested positive for COVID-19 since the vaccination. On unknown date in Feb2021, the patient experienced Missed menstrual period for the same month she received her 2nd dose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported event. The clinical outcome of menstrual disorder was recovered on unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Very mild pain at injection area; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6198) via an unspecified route of administration in the left arm on 17Mar2021 at 11:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, spinal stenosis, arthritis and penicillin allergy from an unknown date. Concomitant medications included buprenorphine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), methocarbamol (MANUFACTURER UNKNOWN) and bisoprolol (MANUFACTURER UNKNOWN) for an unknown indication and since an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 17Mar2021 at 14:00, patient experienced very mild pain at injection area. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The outcome of the event very mild pain at injection area was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Hypoaesthesia, Hypoaesthesia oral, Pain in jaw, Paraesthesia
Clinical narrative: on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; I get really stressed; my cheek and jaw will start to hurt on the left side; my cheek and jaw will start to hurt on the left side; This is a spontaneous report from a non-contactable consumer (patient herself). A female patient of an unspecified age (Age: 27, Unit: not reported) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on an unspecified date, as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue, I get really stressed, and my cheek and jaw will start to hurt on the left side on an unspecified date. Patient stated she was experiencing "weird" symptoms following the first dose of the Pfizer covid vaccine within 30 minutes, and stated turns out her mom  had the same symptoms but worse, it was called trigeminal neuralgia. Patient was worried about getting the second dose tomorrow . Patient still had symptoms, on the left side of her face, tingling and numbness in jaw and cheek and half of her tongue. Patient went to urgent care when it first started and stated that the urgent care doctor did not give a shit about anything. Patient asked for an MRI to scan her head, or a CT scan and she was not sure which one they did. She stated that everything came back fine. Patient called her doctor and his doctor said if it gets worse call him back. Patient stated it got a little better, but it was still there. Patient also reported that when she gets really stressed, her cheek and jaw would start to hurt on the left side and this just started up a week ago. Patient tried to get through to her doctor, but could not get through. Patient was scared that she may get the same diagnosis as her mother and asked if she will be okay if she will not get the second shot because she was worried about not getting the second shot. Patient stated that these symptoms had not gone away, and not as severe like her mothers. The outcome of all events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Stress
Clinical narrative: on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue; I get really stressed; my cheek and jaw will start to hurt on the left side; my cheek and jaw will start to hurt on the left side; This is a spontaneous report from a non-contactable consumer (patient herself). A female patient of an unspecified age (Age: 27, Unit: not reported) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on an unspecified date, as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced on the left side of my face, tingling and numbness in jaw and cheek and half of my tongue, I get really stressed, and my cheek and jaw will start to hurt on the left side on an unspecified date. Patient stated she was experiencing "weird" symptoms following the first dose of the Pfizer covid vaccine within 30 minutes, and stated turns out her mom  had the same symptoms but worse, it was called trigeminal neuralgia. Patient was worried about getting the second dose tomorrow . Patient still had symptoms, on the left side of her face, tingling and numbness in jaw and cheek and half of her tongue. Patient went to urgent care when it first started and stated that the urgent care doctor did not give a shit about anything. Patient asked for an MRI to scan her head, or a CT scan and she was not sure which one they did. She stated that everything came back fine. Patient called her doctor and his doctor said if it gets worse call him back. Patient stated it got a little better, but it was still there. Patient also reported that when she gets really stressed, her cheek and jaw would start to hurt on the left side and this just started up a week ago. Patient tried to get through to her doctor, but could not get through. Patient was scared that she may get the same diagnosis as her mother and asked if she will be okay if she will not get the second shot because she was worried about not getting the second shot. Patient stated that these symptoms had not gone away, and not as severe like her mothers. The outcome of all events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Redness and swelling at vaccination site on arm; Redness and swelling at vaccination site on arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: unknown), via an unspecified route of administration in the left arm on 20Mar2021 at 10:15 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021 at 08:00, the patient experienced redness and swelling at vaccination site on arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events vaccination site erythema and vaccination site swelling was recovering at the time of this report.   Information about lot/batch number cannot be obtained. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Ear pain, Migraine, Neck pain
Clinical narrative: inflammation symptoms- left clavicle pain; general neck pain; area above left ear hurts when touched; migraine on 2nd day; This is a spontaneous report from a non contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 16:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included migraine, hypoglycemia, and obese with chronic inflammation issues like neck pain . The patient had allergies to dog and mold as well as severe seasonal allergies, also she had no known drug allergy. The concomitant medications within two weeks included cetirizine hydrochloride (ZYRTEC), fluticasone propionate (FLONASE), ibuprofen (MANUFACTURER UNKNOWN) for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced migraine on 20Mar2021, inflammation symptoms-left clavicle pain (shoulder pain), general neck pain, area above left ear hurts when touched (ear pain) on 21Mar2021 at 20.00. It was 4-day delayed reaction. The patient was obese with chronic inflammation issues like neck pain. The notable pain on end of clavicle closest to arm and horrific pain above ear on head was new as well as the migraine not being from hormonal change as they were typical. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of shoulder pain, neck pain, migraine and ear pain were not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Trigeminal neuralgia
Clinical narrative: trigeminal neuralgia; This is a spontaneous report from a non-contactable consumer (daughter). A 61-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date (also reported as a couple months later), the patient got symptoms of the Pfizer COVID vaccine - severe pain, got really worse and the physician diagnosed her with trigeminal neuralgia. It was reported that the symptoms were severe. The events were reported as non-serious. The outcome of the event was unknown.   No follow up attempts are possible; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Pain, Pharyngeal swelling, Throat tightness
Clinical narrative: Swelling of throat/Felt like throat was swelling on drive home; Lump node swelling; Body aches; Tiredness; Throat feels tight; This is a spontaneous report from a contactable consumer (patient). A 28-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: ER8727, 28-years-old at the time of vaccination), via an unspecified route of administration, administered in arm left on 18Mar2021 at 16:45 at unknown dose single for covid-19 immunisation. Medical history included urinary reflux, frequent urinary tract infection (UTI)/kidney infections, high blood pressure (BP) (managed through diet) and Penicillin allergy. Patient's concomitant medication included prenatal. Past drug event included Codeine resulted allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Covid was not tested post vaccination. On 18Mar2021 at 17:30 she experienced swelling of throat/felt like throat was swelling on drive home, lump node swelling, body aches, tiredness and throat feels tight. Events resulted in emergency room/department or urgent care. As treatment she received Steroid shot and high dose BENEDRYL. Reported swelling of throat was still able to breath fine. Lump node swelling, body aches, tiredness. Was waited 15 mins and left vaccination site. Felt like throat was swelling on drive home, stopped at a hospital. They gave her a Steroid shot and high dose BENEDRYL. Throat felt tight but better morning after. Seriousness was reported as non-serious by reporter. Outcome of the events was resolving.  No follow up attempts are possible. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea
Clinical narrative: Diffuse headache of moderate strength aggravated by visual sensitivity to light; Loose stool; Faint nausea; This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown) via an unspecified route of administration in the right arm on 22Mar2021 at 11:45 (at the age of 51-years-old) for COVID-19 immunisation. Medical history included hypertension and anxiety. The patient had a history of allergy to sulpha drugs, possibly imaging agents and mild reaction to some shellfish. Concomitant medications included losartan (MANUFACTURER UNKNOWN), atenolol (MANUFACTURER UNKNOWN), quetiapine PRN (MANUFACTURER UNKNOWN), lorazepam PRN (MANUFACTURER UNKNOWN) on an unknown date for unknown indication. The patient had not received any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 22Mar2021, the patient experienced diffuse headache of moderate strength aggravated by visual sensitivity to light, loose stools (but not diarrhea) and faint nausea. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of diffuse headache of moderate strength aggravated by visual sensitivity to light, loose stools (but not diarrhea) and faint nausea was resolving at the time of report.  No follow-up attempts are needed; information on lot/batch number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness, on day 4 the arm pain was quite severe and persisted at rest; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration on left arm on 17Mar2021 at 14:00 as a single dose (at the age of 50-year-old) for COVID-19 immunisation. The patient was not allergic to any medications, food, or other products. The patient medical history was reported as hyperthyroidism. Concomitant medications included synthroid (MANUFACTURER UNKNOWN), valacyclvir (MANUFACTURER UNKNOWN), levonorgestrel (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration on left arm on 24Feb2021 at 14:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 21Mar2021 at 17:00 (first few days after vaccine), the patient experienced minor arm soreness however on day 4 the arm pain was quite severe and persisted even when patients arm was at rest. On day 5 and not as severe but still hurts every time when she moves her arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measure was taken as result of events and included treatment with meloxicam. The clinical outcome of arm pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Lacrimation increased, Myalgia
Clinical narrative: Chills; Fever; Symptoms of tiredness; Muscle aches; watery/weapy eye; This is a spontaneous report from a contactable pharmacist, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: EN6205), via an unspecified route of administration in the left arm on 07Mar2021 at 09:15 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: EL9266), via an unspecified route of administration in the left arm on an unknown date in Feb2021 at 09:00, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have allergies to medications, food, or other products. On 08Mar2021 at 03:00, the patient experienced chills, fever identified in morning and fever ranged from 102 to 103.8 F for several days. Symptoms of tiredness, muscle aches, chills, water/weepy eye were also reported. Therapeutic measures were taken as a result of fever and included treatment with acetaminophen 500mg (single dose) on 10Mar2021. The fever abated on 11Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, tiredness, muscle ache, watering eyes and fever was resolved on 12Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; Fever; Symptoms of tiredness; Muscle aches; watery/weapy eye; This is a spontaneous report from a contactable pharmacist, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: EN6205), via an unspecified route of administration in the left arm on 07Mar2021 at 09:15 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: EL9266), via an unspecified route of administration in the left arm on an unknown date in Feb2021 at 09:00, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have allergies to medications, food, or other products. On 08Mar2021 at 03:00, the patient experienced chills, fever identified in morning and fever ranged from 102 to 103.8 F for several days. Symptoms of tiredness, muscle aches, chills, water/weepy eye were also reported. Therapeutic measures were taken as a result of fever and included treatment with acetaminophen 500mg (single dose) on 10Mar2021. The fever abated on 11Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, tiredness, muscle ache, watering eyes and fever was resolved on 12Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Diarrhoea, Muscle fatigue, Nausea
Clinical narrative: Spotted rash; Muscle fatigue; Sore joints; Intense stomach pains; Nausea; Diarhea; This is a spontaneous report received from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El9262), via an unspecified route of administration in the right arm on 18Feb2021 at 15:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and steroids allergy. Concomitant medication included vitamin B complex (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN), duloxetine (CYMBALTA) and VITAMIN C (MANUFACTURER UNKNOWN); all for unknown indication from unspecified date. The patient previously received cefaclor (CECLORE) and codeine (MANUFACTURER UNKNOWN); both for an unspecified indications and experienced allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6201), via an unspecified route of administration in the right arm on 27Jan2021 at 15:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Mar2021 at 20:00, the patient experienced muscle fatigue, sore joints, intense stomach pains, nausea and diarrhoea. On 12Mar2021, the patient experienced spotted rash and symptoms continued to accumulate. On 15Mar2021, the patient underwent nasal swab test and the result was negative. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events spotted rash, muscle fatigue, sore joints, intense stomach pains, nausea and diarrhoea were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Viral test
Clinical narrative: Spotted rash; Muscle fatigue; Sore joints; Intense stomach pains; Nausea; Diarhea; This is a spontaneous report received from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El9262), via an unspecified route of administration in the right arm on 18Feb2021 at 15:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and steroids allergy. Concomitant medication included vitamin B complex (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN), duloxetine (CYMBALTA) and VITAMIN C (MANUFACTURER UNKNOWN); all for unknown indication from unspecified date. The patient previously received cefaclor (CECLORE) and codeine (MANUFACTURER UNKNOWN); both for an unspecified indications and experienced allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6201), via an unspecified route of administration in the right arm on 27Jan2021 at 15:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Mar2021 at 20:00, the patient experienced muscle fatigue, sore joints, intense stomach pains, nausea and diarrhoea. On 12Mar2021, the patient experienced spotted rash and symptoms continued to accumulate. On 15Mar2021, the patient underwent nasal swab test and the result was negative. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events spotted rash, muscle fatigue, sore joints, intense stomach pains, nausea and diarrhoea were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 0.08
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ear pain, Fatigue, Headache, Myalgia
Clinical narrative: Massive headache; TIREDNESS; Muscle pain; fever; ears ache; nausea; chills; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727), via an unspecified route of administration in the right arm on 18Mar2021 at 12:30 (at the age of 55-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient has allergies to codeine. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2020, the patient experienced massive headache that she couldnt get out of bed for 2 days, tiredness, muscle pain, chills, fever, ears ache, nausea for 5 days most lasted 3 to 4 days. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the reported events massive headache, tiredness, muscle pain, chills, fever, ears ache and nausea was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 0.08
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Massive headache; TIREDNESS; Muscle pain; fever; ears ache; nausea; chills; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727), via an unspecified route of administration in the right arm on 18Mar2021 at 12:30 (at the age of 55-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient has allergies to codeine. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2020, the patient experienced massive headache that she couldnt get out of bed for 2 days, tiredness, muscle pain, chills, fever, ears ache, nausea for 5 days most lasted 3 to 4 days. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the reported events massive headache, tiredness, muscle pain, chills, fever, ears ache and nausea was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Paraesthesia, Rash
Clinical narrative: Face became hot and flushed; The right side of face had a slight rash; Face and forearms were tingly; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in the right arm on 22Mar2021 at 17:30 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not take any concomitant medications. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021 at 19:00, approximately 1.5 hours after receiving the vaccine, the patient's face became hot and flushed and the right side of the face had a slight rash, face and forearms were tingly, similar to the feeling of novocaine wearing off. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events hot flushes facial, rash face and tingling was recovered on an unknown date in Mar2021.   Information on the lot/batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Pain assessment
Clinical narrative: Started to feel minor pain on right wrist, the outside joint bone; Numb sensation through the outside rim of right palm as well; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in the left arm on 18Mar2021 at 14:58 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not take any concomitant medications. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Mar2021 at 08:00, the patient experienced minor pain on right wrist, the outside joint bone. When the patient washed hands, could feel the numb sensation through the outside rim of right palm as well. The bone pain persisted from 19Mar2021 to present day, 23Mar2021. The numbness on outside rim of palm also persisted. On a scale from 1- 10, the pain was assessed as 1 or 2, minor pain and the numbness was about the same category. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events wrist pain and numbness in hands was not recovered at the time of this report.   Information on the lot/batch number has been requested.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Lymphadenopathy, Pain in extremity
Clinical narrative: swollen lymph node; Hip ache; lower back aches; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 56-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: PGZER EP7534), via unspecified route of administration, in left arm on 20Mar2021 (at the age of 56-years-old) at 14:30 as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes and the patient was allergic to ace inhibitors. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 21Mar2020 at 01:00, after the vaccination the patient experienced sore arm after first day, on third day i.e.,23Mar2021 with swollen lymph node in the same arm and hip and lower back aches. Therapeutic measures and treatments were not taken for the reported events. The clinical outcome of the events pain in arm, swollen lymph node, hip pain, and lower back aches was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dry mouth, Headache, Lethargy
Clinical narrative: Dry mouth; Lethargy; Severe chills; Fever of 101.4; Headache; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 15:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical histories. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 14:00 (24 hours post vaccination), the patient experienced severe chills, fever of 101.4, dry mouth, severe headache and lethargy. The patient experienced severe headache for three days post vaccination and was still having a milder headache in the morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of chills, fever, dry mouth and lethargy was resolved with sequelae (reported as recovered with lasting effects). The clinical outcome of the event headache was recovering at the time of this report.   Information about lot/batch number cannot be obtained. No further information expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Dry mouth; Lethargy; Severe chills; Fever of 101.4; Headache; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 15:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical histories. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 14:00 (24 hours post vaccination), the patient experienced severe chills, fever of 101.4, dry mouth, severe headache and lethargy. The patient experienced severe headache for three days post vaccination and was still having a milder headache in the morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of chills, fever, dry mouth and lethargy was resolved with sequelae (reported as recovered with lasting effects). The clinical outcome of the event headache was recovering at the time of this report.   Information about lot/batch number cannot be obtained. No further information expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Limb mass, Myalgia
Clinical narrative: Muscle aches; Large red lump in arm; This is a spontaneous report received from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included ethinylestradiol; etonogestrel (NUVARING) and triamcinolone acetonide (NASACORT); both for unknown indications from unknown dates. The patient was allergic to ibuprofen (MANUFACTURER UNKNOWN) and aspirin (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Mar2021 at 07:00, the patient had a large red lump in arm that lasted until 22Mar2021. On 22Mar2021, the patient experienced muscle aches. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events large red lump in arm and muscle aches. The clinical outcome of the event large red lump in arm was recovered on 22Mar2021 while that of muscle aches was not recovered at the time of the report.  Information on lot number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Pain
Clinical narrative: Major body aches; Muscle aches; Joint pain; Head ache; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Mar2021 at 12:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, days four post vaccine, the patient experienced major body aches, muscle aches, joint pain and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events general body pain, muscle ache, joint pain and headache was not recovered at the time of this report.   Information on the lot/batch number has been requested.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Fever; Chills; Red swollen arm with knot at injection site; Red swollen arm with knot at injectionsite; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EH6208) via an unspecified route of administration in the arm right on 19Mar2021at 11:15 (at the age of 62-year-old) as a single dose for COVID-19 Immunisation. Medical history was reported as thyroid and high blood pressure Concomitant medications were reported as lisinopril (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and escitalopra (MANUFACTURER UNKNOWN) for an unknown indication from unspecified date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9269) via an unspecified route of administration in the arm left on 26Feb2021at 11:30 (at the age of 62-year-old) as a single dose for COVID-19 Immunisation. The patient did not have allergies to medications, food, or other product. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not tested for COVID-19. The patient had not symptoms associated with COVID-19. On 20Mar2021 at 14:00, the patient experienced fever, chills and red (vaccination site erythema) swollen arm with knot at injection site (vaccination site swelling). The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events fever, chills and vaccination site erythema and vaccination site swelling was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pyrexia, SARS-CoV-2 test
Clinical narrative: fever uncontrollable chills; Malaise; This is a spontaneous report from a contactable consumer, the Patient. A 45-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6208) via an unspecified route of administration in the left arm on 12Mar2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had shellfish and environmental allergies. Concomitant medications included tetracycline hydrochloride (TRICOR), rosuvastatin calcium (CRESTOR), amlodipine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), and cetirizine hydrochloride (ZYRTEC) all for unknown indication from unknown date. The patient was not enrolled in clinical trial. The patient had not tested positive for COVID-19 since the vaccination. On 20Mar2021 at 18:00 (8 days after vaccination), the patient experienced bedtime, fever, uncontrollable chills and malaise. In the morning the patient felt fine. But the same events reoccurred again 10 days after injection. The patient had COVID-19 virus test on 12Mar2021 and resulted negative. The patient did not receive treatment for the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever chills and malaise was not resolved (reoccurred after 10 days of vaccination) at the time of this report.   No follow-up attempts are needed. No further information is expected.